155 related articles for article (PubMed ID: 29500172)
1. Introduction to a review series on Hodgkin lymphoma: change is here.
Sehn LH
Blood; 2018 Apr; 131(15):1629-1630. PubMed ID: 29500172
[No Abstract] [Full Text] [Related]
2. Prognostic Biomarkers for Hodgkin Lymphoma.
Staege MS; Kewitz S; Bernig T; Kühnöl C; Mauz-Körholz C
Pediatr Hematol Oncol; 2015; 32(7):433-54. PubMed ID: 26380871
[TBL] [Abstract][Full Text] [Related]
3. Response-adapted therapy in Hodgkin lymphoma.
Broadfoot J; Johnson PWM
Hematol Oncol; 2017 Jun; 35 Suppl 1():33-36. PubMed ID: 28591415
[No Abstract] [Full Text] [Related]
4. An anaplastic T-cell lymphoma mimicking classical Hodgkin lymphoma.
Wang HY; Jaffe ES
Blood; 2018 Mar; 131(11):1262. PubMed ID: 29545405
[No Abstract] [Full Text] [Related]
5. Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins.
Cano I; Lozano M; Rodríguez A; Mate A; Adrados M; López Mdel M; Carro R; Montes-Moreno S
Histopathology; 2010 Jul; 57(1):159-62. PubMed ID: 20653789
[No Abstract] [Full Text] [Related]
6. Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma.
Mata E; Fernández S; Astudillo A; Fernández R; García-Cosío M; Sánchez-Beato M; Provencio M; Estévez M; Montalbán C; Piris MA; García JF
Blood Cancer J; 2019 Mar; 9(3):34. PubMed ID: 30858359
[No Abstract] [Full Text] [Related]
7. Hodgkin's lymphoma.
Tsang RW; Hodgson DC; Crump M
Curr Probl Cancer; 2006; 30(3):107-58. PubMed ID: 16740424
[No Abstract] [Full Text] [Related]
8. Plasma cells in classical Hodgkin lymphoma: a new player in the microenvironment?
Visser L
Br J Haematol; 2019 Jan; 184(2):119-120. PubMed ID: 30485402
[No Abstract] [Full Text] [Related]
9. A practical approach to the diagnosis of Hodgkin lymphoma.
Listinsky CM
Am J Clin Pathol; 2002 Jun; 117 Suppl():S76-94. PubMed ID: 14569804
[TBL] [Abstract][Full Text] [Related]
10. Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies.
Mottok A; Steidl C
Blood; 2018 Apr; 131(15):1654-1665. PubMed ID: 29500175
[TBL] [Abstract][Full Text] [Related]
11. Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL.
Tseng D; Jones CD; Anderson M; Warnke R; Zehnder JL; Miklos DB
Bone Marrow Transplant; 2011 Dec; 46(12):1576-8. PubMed ID: 21258419
[No Abstract] [Full Text] [Related]
12. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
[No Abstract] [Full Text] [Related]
13. [Hodgkin lymphoma and non-Hodgkin lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2013 Jan; 54(1):81-8. PubMed ID: 23391651
[No Abstract] [Full Text] [Related]
14. Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases.
Went P; Tzankov A; Schwaller J; Passweg J; Roosnek E; Huard B
Exp Hematol; 2008 May; 36(5):533-4. PubMed ID: 18439487
[No Abstract] [Full Text] [Related]
15. I. Hodgkin lymphoma: special challenges and solutions.
Connors JM
Hematol Oncol; 2015 Jun; 33 Suppl 1():21-4. PubMed ID: 26062048
[No Abstract] [Full Text] [Related]
16. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin disease/lymphoma.
Hoppe RT; Advani RH; Ambinder RF; Bierman PJ; Bloomfield CD; Blum K; Dabaja B; Djulbegovic B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hudson MM; Kaminski MS; Love G; Maloney DG; Mansur D; Mauch PM; Moore JO; Schilder RJ; Weiss LM; Winter JN; Yahalom J; Zelenetz AD;
J Natl Compr Canc Netw; 2008 Jul; 6(6):594-622. PubMed ID: 18597713
[No Abstract] [Full Text] [Related]
18. Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.
Goel A; Fan W; Patel AA; Devabhaktuni M; Grossbard ML
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):261-70. PubMed ID: 24650975
[TBL] [Abstract][Full Text] [Related]
19. Options for first line therapy of Hodgkin lymphoma.
Longley J; Johnson PWM
Hematol Oncol; 2019 Jun; 37 Suppl 1(Suppl Suppl 1):82-86. PubMed ID: 31187527
[No Abstract] [Full Text] [Related]
20. Hodgkin disease/lymphoma. Clinical practice guidelines in oncology.
Hoppe RT; Advani RH; Bierman PJ; Bloomfield CD; Buadi F; Djulgegovic B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Kaminski MS; Love G; Maloney DG; Mauch PM; Moore JO; Schilder RJ; Weiss L; Winter JN; Yahalom J; Zelenetz AD;
J Natl Compr Canc Netw; 2006 Mar; 4(3):210-30. PubMed ID: 16507269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
